Dow Down 0.92% Nasdaq Down 0.83%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
137.61 Down 2.94(2.09%) Oct 22, 4:00PM EDT
|After Hours : 130.15 Down 7.46 (5.42%) Oct 22, 5:23PM EDT
Prev Close:140.55
Open:140.15
Bid:128.71 x 100
Ask:N/A
1y Target Est:169.06
Beta:0.93
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:137.34 - 141.80
52wk Range:70.64 - 172.98
Volume:921,486
Avg Vol (3m):1,833,510
Market Cap:8.76B
P/E (ttm):152.39
EPS (ttm):0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SLXP

Comparison

Symbol% ChgMkt Cap
SLXPDown 2.09%8.76B
BAYRYDown 0.34%109.82B
GSKUp 1.79%106.67B
WCRX 0.00%N/A

Key Statistics

Forward P/E (1 yr):19.52
P/S (ttm):7.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :6.16
Quarterly EPS Est (Sep-14) :1.56
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback